Accelr8 Technology Corporation - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Accelr8 Technology Corporation Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Accelr8 Technology Corporation. The Company's principal activity is to develop and commercialize innovative, integrated system for rapid identification of bacteria and their antibiotic resistance in critically ill patients. The major products include BACcelr8r(tm), OptiChem(r), OptArray(TM). BACcelr8r(tm) intended to be used in clinical diagnostics for life-threatening bacterial infections. OptiChem(r) is into surface coatings and assay processing methods. OptArray(TM) produces micro arraying slides and also develops OptiPlate(TM) arrayable microtiter plates. The Company is granted license to Schott Jenaer Glas GmbH (SCHOTT), for manufacturing and marketing OptiChem microarraying products. The major trade marks include BACcelr8r, OptArray(TM),OptiChem(R), OptiPlate(TM),QuanDx(TM),YoDx(TM) and Quantum Microbiology(TM). The Company's office and laboratory is situated in Colorado.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report